(Q36641213)

15 August 2017

p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis (English)

1 reference

15 August 2017

1 reference

7

Kosma VM

1 reference

15 August 2017

Ropponen KM

1

1 reference

15 August 2017

Kellokoski JK

2

1 reference

15 August 2017

Lipponen PK

3

1 reference

15 August 2017

Pietiläinen T

4

1 reference

15 August 2017

Eskelinen MJ

5

1 reference

15 August 2017

Alhava EM

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

81

1 reference

15 August 2017

1

1 reference

15 August 2017

133-140

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690662

15 August 2017

0 references

cites work

Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

Identification of a novel AP-2 consensus DNA binding site.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

Genetic determinants of p53-induced apoptosis and growth arrest

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

Absence of mutations and identification of two polymorphisms in the SSCP and sequence analysis of p21CK1 gene in malignant gliomas

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374357

Tumor suppression by p21WAF1

4 December 2018

1 reference

12 December 2020

A frequent alteration of p53 gene in carcinoma in adenoma of colon

1 reference

12 December 2020

Immunohistochemical detection of p21waf1/cip1/sdi1 and p53 proteins in formalin-fixed, paraffin-embedded tissue sections of colorectal carcinoma

1 reference

12 December 2020

WAF1 expression and p53 mutations in human colorectal cancers

1 reference

12 December 2020

The expression of waf-1, p53 and bcl-2 in prostatic adenocarcinoma

1 reference

12 December 2020

Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas

1 reference

12 December 2020

Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry

1 reference

12 December 2020

Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression

1 reference

12 December 2020

Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer

1 reference

12 December 2020

Molecular mechanisms of melanoma metastasis

1 reference

12 December 2020

Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia

1 reference

12 December 2020

Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma

1 reference

12 December 2020

Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells

1 reference

12 December 2020

p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

p53 protein in endometrial cancer is related to proliferative activity and prognosis but not to expression of p21 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

WAF1/CIP1 protein expression in human breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

Prognosis of ovarian carcinomas: prediction by histoquantitative methods

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

Reduced messenger RNA expression level ofp21CIP1 in human colorectal carcinoma tissues and its association withp53 gene mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

Immunohistochemical localization of p21(WAF1/CIP1) in normal, hyperplastic, and neoplastic uterine tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690662

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690662

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

10487624

1 reference